Our study was the first to determine whether pre-treatment tumor expressions of survivin, p53, cyclin D1, OPN and FN might help to predict the response to naCHT in pediatric inoperable and/or metastatic MPNST. Here, CCND1 is linked to malignant peripheral nerve sheath tumor.